Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeName |
MOR202
TJ202 |
| gptkbp:ATCCode |
gptkb:L01XC43
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:MorphoSys
|
| https://www.w3.org/2000/01/rdf-schema#label |
felzartamab
|
| gptkbp:mechanismOfAction |
CD38 inhibition
|
| gptkbp:target |
gptkb:CD38
|
| gptkbp:usedFor |
multiple myeloma
|
| gptkbp:bfsParent |
gptkb:I-Mab_Biopharma
|
| gptkbp:bfsLayer |
7
|